Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Andrew Westfall (NPI 1003989781)

Field	Value
Entity Type	Individual
Organization	Andrew Westfall
Address	2450 12th Street Se
City	Salem
State	OR
ZIP	97302
Taxonomy	Ophthalmology Physician
NPI Enumerated	November 17, 2006

Payer Source	Total Paid
Medicare	$1.1M
Medicaid	$0

Key Findings

This provider’s Medicare business is the sole visible payer relationship: total Medicare revenue is $1.1M and there is no Medicaid billing on file, so the practice functions effectively as a Medicare-focused operation rather than a dual‑payer clinic. That concentration means any reimbursement or coverage changes to Medicare policy will have outsized impact on the provider’s revenue base.

Revenue is highly concentrated in a very small set of intravitreal injection codes: the top three Medicare codes account for 85.8% of total Medicare revenue, led by J0178 ($605.7K, 53.9%), followed by J2777 ($269.7K, 24.0%) and 67028 ($88.3K, 7.9%). This preponderance of a few codes indicates the practice’s financial performance is driven primarily by high-volume injectable therapies rather than a broad mix of office visits or ancillary services.

The mix of dominant codes points to a retina-focused ophthalmology practice that performs large volumes of intravitreal drug administration and allied procedures: J0178 (injection, aflibercept) shows 892 claims and J2777 (injection, faricimab) shows 9.3K claims, while 67028 (intravitreal injection as a separate procedure) has 981 claims. By contrast, standard office E/M and new-patient comprehensive ophthalmology codes contribute relatively small shares of revenue, suggesting the operation is procedure-driven and oriented around retinal therapeutic services.

On competitive standing the provider appears to be a modest national participant rather than a dominant center for its top drugs: J0178 ranks #1399 of 3204 (56th percentile; typical, unremarkable volume), J2777 ranks #1060 of 2039 (48th percentile; typical, unremarkable volume), and 67028 ranks #1410 of 4255 (67th percentile; typical, unremarkable volume). These ranks indicate measurable clinical activity in these codes but not outlier market leadership at the national level.

Several ancillary codes show relatively high comparative activity and may reflect supporting capabilities: J7999 (compounded drug) generates $34.1K and ranks #173 of 1333 (87th percentile; typical, unremarkable volume), and 92134 (retinal OCT imaging) generates $27.6K and ranks #2187 of 26868 (92th percentile; typical, unremarkable volume). The elevated percentiles for these diagnostics and compound-drug billing suggest an operational reliance on in‑house imaging and compounded medications as part of the treatment workflow.

Office visit codes form a modest part of billed services and revenue: 92014 accounts for $38.7K (455 claims, 3.4% of Medicare revenue) and 99214 accounts for $17.6K (205 claims, 1.6% of Medicare revenue). The relative scale of E/M revenue versus procedural/injection revenue reinforces that patient throughput is likely centered on procedure sessions rather than prolonged clinic-based medical management.

The provider has long tenure in the Medicare program, with an NPI enumerated on 2006-11-17 (~20 years ago), indicating an established billing history and likely an enduring local presence. That longevity supports interpretation of the current code mix as an operational choice rather than a short‑term billing anomaly.

From a payer-analytic and contracting perspective, this profile implies concentration risk and clear targets for utilization management and negotiation: a few high-revenue injection codes (the top three at 85.8%) plus notable use of compounded drugs and retinal imaging define the service line to benchmark. Given the absence of Medicaid revenue, payers should treat reimbursement sensitivity or clinical guideline changes in Medicare as primary drivers of future revenue variance for this provider.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

15 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	890	$680	$605.7K
J2777	Injection, faricimab‑svoa, 0.1 mg	9,300	$30	$269.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	980	$90	$88.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	460	$90	$38.7K
J7999	Compounded drug, not otherwise classified	470	$70	$34.1K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	990	$30	$27.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	210	$90	$17.6K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	120	$100	$12.7K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	110	$110	$12.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	120	$60	$7.4K

Showing 1–10 of 15

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

Andrew Westfall — 0 of 15 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

15 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	29	60	840	$680	$623.7K
J2777	20	30	10,050	$30	$527.6K
67028	26	70	580	$90	$72.3K
J7999	13	50	270	$70	$23.4K
92014	53	440	110	$80	$16K
92235	5	30	60	$100	$11.1K
99214	1,208	6,070	80	$70	$10.3K
92134	36	390	80	$30	$8.1K
99215	1,725	2,170	40	$100	$6.7K
99213	1,449	5,480	60	$50	$5.7K

Showing 1–10 of 15

Related Providers

Other providers that share a Tax Identification Number (TIN) with Andrew Westfall, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Retina Consultants, LLP	OR	Ophthalmology Physician	$0	$6.6M
Monica Michelotti	OR	Ophthalmology Physician	$2.5M	$0
Scott Mcclintic	OR	Ophthalmology Physician	$1.7M	$0
Justin Baynham	OR	Ophthalmology Physician	$1.4M	$0
Jessica Weinstein	OR	Retina Specialist (Ophthalmology) Physician	$691.2K	$49.8K

Nearby Providers

Other providers in the same ZIP code as Andrew Westfall, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Crc Health Oregon, LLC	OR	Methadone Clinic	$485.5K	$26.1M
Salem Psychiatric Associates PC	OR	Clinical Social Worker	$0	$22.7M
Shangri-la Corporation	OR	Mental Illness Community Based Residential Treatment Facility	$0	$13.5M
Cascade Infectious Diseases And Infusion LLC	OR	Infusion Therapy Clinic/Center	$0	$9.6M
Salem Pediatric Clinic	OR	Pediatrics Physician	$0	$9M
Silver Falls Dermatology, LLC	OR	Dermatology Physician	$0	$6.8M
Cascade Sleep Supply, LLC.	OR	Durable Medical Equipment & Medical Supplies	$0	$6.1M
Creating Pathways	OR	Speech-Language Pathologist	$0	$5.7M
Salem Pulmonary Associates P.C.	OR	Pulmonary Disease Physician	$0	$4.8M
Hhhkc Dental LLC	OR	Oral and Maxillofacial Surgery (Dentist)	$0	$4.7M

Andrew Westfall — Billing Profile & Reimbursement Data

Sign up for Andrew Westfall — Billing Profile & Reimbursement Data policy alerts

Andrew Westfall — Billing Profile & Reimbursement Data

Sign up for Andrew Westfall — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References